Vicarious Surgical (RBOT) Share-based Compensation (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Share-based Compensation of $2.0 million for Q3 2025, down 30.23% year-over-year from $2.9 million in Q3 2024, and down 67.45% quarter-over-quarter from $6.3 million in Q2 2025.
Vicarious Surgical (RBOT) Share-based Compensation (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Share-based Compensation for 6 consecutive years, with $2.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Share-based Compensation fell 30.23% year-over-year to $2.0 million; the TTM figure through Sep 2025 stood at $10.6 million (down 13.03% YoY), while the FY2024 annual figure was $11.9 million, down 10.27% from the prior year.
- Share-based Compensation declined to $2.0 million in Q3 2025 per RBOT's latest filing, from $6.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.3 million in Q2 2025 and bottomed at $256000.0 in Q1 2021.
- Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $2.9 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 894.28% — and 2025, when it slumped 30.23%.
- Vicarious Surgical's Share-based Compensation stood at $2.7 million in 2021, then soared by 31.35% to $3.5 million in 2022, then slipped by 13.36% to $3.1 million in 2023, then retreated by 8.62% to $2.8 million in 2024, then dropped by 27.08% to $2.0 million in 2025.
- Business Quant data shows RBOT's Share-based Compensation at $2.0 million in Q3 2025, $6.3 million in Q2 2025, and $2.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.32 Mn |